プロフィールへ戻る

論文一覧
公開件数:100件
No. 著者・共著者名 発表論文の標題 掲載誌名 巻号頁 出版日 ISSN DOI
1 柳田憲吾、萩生田大介、朽津有紀、鈴木杏奈、井上 航、松本梨沙、龍華慎一郎、三枝 信、村雲芳樹、長塩 亮、鉢村和男、佐藤雄一
Reverse-phase protein array法を用いた血清診断マーカーの探索
電気泳動
61/ 1, 23-28
2017/08

10.2198/electroph.61.23
2 長塩 亮、萩生田大介、朽津有紀、柳田憲吾、鉢村和男、佐藤雄一
癌幹細胞様微乳頭肺腺癌細胞株を用いたプロテオーム解析
電気泳動
61/ 1, 39-44
2017/08

10.2198/electroph.61.39
3 佐藤雄一
自己抗体を用いた腫瘍マーカー候補タンパク質の獲得
電気泳動
61/ 1, 1-4
2017/08

10.2198/electroph.61.1
4 Igawa S, Otani S, Nakahara Y, Ryuge S, Hiyoshi Y, Fukui T, Mitsufuji H, Kubota M, Katagiri M, Sato Y, Sasaki J, Masuda N.
Phase I study of Nedaplatin, a platinum based antineoplastic drugs, combined woth nab-paclitaxel in patients with advanced squamous non-small cell lung cancer.
Invest New Drugs
35
2017/06

10.1007/s10637-017-0472-x
5 Igawa S, Sato Y, Ryuge S, Ichinoe M, Katono K, Hiyoshi Y, Otani S, Nagashio R, Nakashima H, Katagiri M, Sasaki J, Murakumo Y, Satoh Y, Masuda N.
Impact of PD-L1 expresion in patients with surgically resected non-small-cell lung cancer.
Oncology
92/ 5
2017/05

10.1159/000458412
6 Ryuge S, Sato Y, Nagashio R, Hiyoshi Y, Katono K, Igawa S, Nakashima H, Shiomi K, Ichinoe M, Murakumo Y, Saegusa M, Satoh Y, Masuda N.
Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial mesenchymal transition related markers.
PLOS ONE
12/ 3, e0173886
2017/03

10.1371/journal.pone.0173886
7 Igawa S, Ryuge S, Ichinoe M, Nakashima H, Otani S, Nakahara Y, Fukui T, Sasaki J, Kubota M, Katagiri M, Murakumo Y, Satoh Y, Sato Y, Masuda N.
Impact of EGFR-tyrosine kinase inhibitors on postoperative recurrent non-small-cell lung cancer harboring EGFR mutations.
Oncol Res Treat
40/ 1-2
2017/02

10.1159/000455147
8 Kuji S, Watanabe R, Sato Y, Iwata T, Hirashima Y, Takekuma M, Ito I, Abe M, Nagashio R, Omae K, Aoki D, Kameya T.
A new marker insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: analysis of 37 cases.
Gynecol Oncol

2017/01

10.1016/j.ygyno.2016.11.020
9 Kubo K, Murabayashi C, Kotachi M, Suzuki A, Mori D, Sato Y, Onozuka M, Azuma K, Iinuma M.
Tooth loss early in life suppresses neurogenesis and synaptophysin expression in the hipocampus and impairs learning in mice.
Arch Oral Biol
74, 21-27
2017/01

10.1016/j.archoralbio.2016.11.005
10 Maejima H, Kobayashi M, Yanagita K, Hamada Y, Nagashio R, Sato Y, Amoh Y.
Valosin-containing protein is a possible sero-diagnostic marker of psoriatic arthritis.
Biomed Res-India
28/ 1, 442-446
2017/01
0970-938X

11 Nishimura M, Nagashio R, Sato Y, Hasegawa T.
Late Somatyic Gene 2 disrupts parental spheroids cooperatively with Volvox hatching enzyme A in Volvox.
Planta
244
2016/12

10.1007/s00425-016-2599-y
12 Suzuki A, Iinuma M, Hayashi S, Sato Y, Azuma K, Kubo KY.
Maternal chewing during prenatal stress ameliorates stress-induced hypomyelination, synaptic slterations, and learning impairment in mouse offspring.
Brain Res
1651, 36-43
2016/09

10.1016/j.brainres.2016.09.007
13 Miyake H, Mori D, Katayama T, Fujiwara S, Sato Y, Azuma K, Kubo K.
Novel stress increases hypothalamic-pituitary-adrenal activity in mice with a rised bite.
Arch Oral Biol
68, 55-60
2016/08

10.1016/j.archoralbio.2016.03.020
14 Igawa S, Sato Y, Ishihara M, Kasajima M, Kusuhara S, Nakahara Y, Otani S, Fukui T, Katagiri M, Sasaki J, Masuda N.
EGFR mutation genotype impact on the efficacy of pemetrexed in patients with nonsquamous nonsmall cell lung cancer.
Asian Pac J Cancer Prev
17/ 7, 3249-3253
2016/08

10.14456/APJCP.2016.17.7.3249
15 Masuzawa M, Masuzawa M, Arakawa N, Hamada Y, Tamauchi H, Morita M, Nishiyama S, Sato Y.
Immune milk suppresses herpes simplex virus type 1.
J Nutr Sci Vitaminol
62/ 1, 67-70
2016/02
1881-7742
10.3177/jnsv.62.67
16 Katono K, Sato Y, Jiang S-X, Kobayashi M, Saito K, Nagashio R, Ryuge S, Satoh Y, Saegusa M, Masuda N.
Clinicopathological significance of S100A10 expression in lung adenocarcinomas.
Asian Pac J Cancer Prev
17/ 1, 289-294
2016/02

10.7314/APJCP.2016.17.1.289
17 Yanagita K, Nagashio R, Ryuge S, Katono K, Jiang S-X, Tsuchiya B, Nakashima H, Fukuda E, Goshima N, Saegusa M, Satoh Y, Masuda N, Sato Y.
Serum anti-Gal-3 autoantibody is a predictive marker of the efficacy of platinum-based chemotherapy against pulmonary adenocarcinoma.
Asian Pac J Cancer Prev
16/ 17, 7959-7966
2015/12

10.7314/APJCP.2015.16.17.7959
18 Saito K, Kobayashi M, Nagashio R, Ryuge S, Katono K, Nakashima H, Tsuchiya B, Jiang SX, Saegusa M, Satoh Y, Masuda N, Sato Y.
S100A16 is a prognostic marker for lung adenocarcinomas.
Asian Pac J Cancer Prev
16/ 16, 7039-7044
2015/11

10.7314/APJCP.2015.16.16.7039
19 Kobayashi M, Nagashio R, Jiang S-X, Tsuchiya B, Ryuge S, Katono K, Nakashima H, Fukuda E, Goshima N, Satoh Y, Masuda N, Saegusa M, Sato Y.
Calnexin is a novel sero-diagnostic marker for lung cancer.
Lung Cancer
90, 342-345
2015/10

10.1016/j.lungcan.2015.08.015
20 Yasuoka Y, Sato Y, Healy JM, Noguchi H, Kawahara K.
pH-sensitive expression of calcium-sensing receptor (CaSR) in type-B intercalated cells of the cortical collecting ducts (CCD) in mouse kidny.
Clin Exp Nephrol
19, 771-782
2015/10

10.1007/s10157-014-1063-1
21 Maejima H, Katayama C, Taniguchi T, Aki R, Nishiyama H, Yanagita K, Sato Y, Tinazzi I, Watarai A, Amoh Y.
Japanese version of the early psoriatic arthritis screening questionnaire (EARP).
J Dermatol
42, 1-4
2015/09

10.1111/1346-8138.13092
22 Nakashima H, Jiang SX, Sato Y, Hoshi K, Matsumoto T, Nagashio R, Kobayashi M, Matsuo Y, Shiomi K, Hayakawa K, Saegusa M, Satoh Y.
Prevalent and up-regulated vimentin expression in micropapillary components of lung adenocarcinomas and its adverse prognostic significance.
Pathol Int
65/ 4, 183-192
2015/04

10.1111/pin.12257
23 Katono K, Sato Y, Jiang SX, Kobayashi M, Nagashio R, Ryuge S, Fukuda E, Goshima N, Satoh Y, Saegusa M, Masuda N.
Prognostic significance of MYH9 expression in resected non-small cell lung cancer.
PLOS ONE
10/ 3, e0121460
2015/03

10.1371/journal.pone.0121460
24 Tsumura H, Matsumoto K, Ikeda M, Yanagita K, Hirano S, Hagiwara M, Nagashio R, Fujita T, Sato Y, Iwamura M.
High expression level of preoperative serum uroplakin III is associated with biologically aggressive bladder cancer.
Asian Pac J Cancer Prev
16/ 4, 1539-1543
2015/03

10.7314/APJCP.2015.16.4.1539
25 Nagashio R, Ueda J, Ryuge S, Nakashima H, Jiang S-X, Kobayashi M, Yanagita K, Katono K, Satoh Y, Masuda N, Murakumo Y, Hachimura K, Sato Y.
Diagnostic and prognostic significances of MUC5B and TTF-1 expressions in resected non-small cell lung cancer.
Sci Rep
5, 8649
2015/03

10.1038/srep08649
26 Nishi M, Matsumoto K, Kobayashi M, Yanagita K, Matsumoto T, Nagashio R, Ishii D, Fujita T, Sato Y, Iwamura M.
Serum expression of S100A6 is a potential detection marker in patients with urothelial carcinoma in the urinary bladder
Biomed Res
35/ 6, 351-356
2014/12

10.2220/biomedres.35.351
27 Matsumoto K, Ikeda M, Matsumoto T, Nagashio R, Nishimori T, Tomonaga T, Nomura F, Sato Y, Kitasato H, Iwamura M.
Serum periplakin as a potential biomarker for urothelial carcinoma of the urinary bladder.
Asian Pac J Cancer Prev
15/ 22, 9927-9931
2014/12

10.7314/APJCP.2014.15.22.9927
28 荒井ゆり子、西村由香里、川村瑞穂、松本和将、三枝 信、佐藤雄一、大部 誠、服部 学
尿道原発の明細胞腺癌の1例
神奈川県臨床細胞学会誌
19/ 1, 30-34
2014/07


29 Maejima H, Nagashio R, anagita K, Hamada Y, Amoh Y, Sato Y, Katsuoka K.
Moesin and stress-induced phosphoprotein-1 are possible sero-diagnostic markers of psoriasis.
PLOS ONE
9/ 7, e101773
2014/07

10.1371/journal.pone.0101773
30 Matsumoto K, Ikeda M, Sato Y, Kuruma H, Kamata Y, Nishimori T, Tomonaga T, Nomura F, Egawa S, Iwamura M.
Loss of periplakin expression is associated with pathological stage and cancer-specific survival in patients with urothelial carcinoma of the urinary bladder.
Biomed Res
35/ 3, 201-206
2014/06
0388-6107
10.2220/biomedres.35.201
31 Tabata K, Matsumoto K, Minami S, Ishii D, Nishi M, Fujita T, Saegusa M, Sato Y, Iwamura M.
Nestin is an independent predictor of cancer-specific survival after radical cystectomy in patients with urothelial carcinoma of the bladder
PLOS ONE
9/ 5, e91548
2014/05

10.1371/journal.pone.0091548
32 Matsumoto K, Ikeda M, Hirayama T, Nishi M, Fujita T, Hattori M, Sato Y, Ohbu M, Iwamura M.
Clinical value of dividing false positive urine cytology findings into three categories: atypical, indeterminate, and suspicious of malignancy.
Asian Pac J Cancer Prev
15/ 5, 2251-2255
2014/04

10.7314/APJCP.2014.15.5.2251
33 Kobyashi M,Nagashio R, Ryuge S, Murakami Y, Yanagita K, Nakashima H, Matsumoto T, Jiang SX, Saegusa M, Satoh Y, Masuda N, Sato Y.
Acquisition of useful sero-diagnostic autoantibodies using the same patients' sera and tumor tissues.
Biomed Res
35/ 2, 133-143
2014/04
0388-6107
10.2220/biomedres.35.133
34 Minami S, Nagashio R, Ueda J, Matsumoto K, Goshima N, Hattori M, Hachimura K, Iwamura M, Sato Y.
Detection of tumor-associated antigens in culture supernatants using autoantibodies in sera from patients with bladder cancer.
Biomed Res
35/ 1, 25-35
2014/02

10.2220/biomedres.35.25
35 Ryuge S, Sato Y, Jiang SX, Wang G, Kobayashi M, Nagashio R, Katono K, Iyoda A, Satoh Y, Masuda N.
The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
Lung Cancer
82/ 1, 134-138
2013/10

10.1016/j.lungcan.2013.06.010
36 Suzuki Y, Yoshida T, Wang G, Aoki T, Katayama T, Miyamoto S, Miyazaki K, Iwabuchi K, Danbara M, Nakayama M, Horie R, Nakamine H, Sato Y, Nakamura N, Niitsu N
Incidence and clinical significance of abberrant T-cellmarker expression on diffuse large B-cell lymphoma cells.
Acta Hematologica
130, 230-237
2013/06

10.1159/000348550
37 Kurosaka S, Matsumoto K, Irie A, Hirayama T, Nishi M, Fujita T, Satoh T, Sato Y, Iwamura M, Yoshida K.
Anaplastic lymphoma kinase (ALK) and p53 are potentially useful markers to distinguish inflammatory myofibroblastic tumor.
Open J Urol
3/ 2, 71-74
2013/05

10.4236/oju.2013.32014
38 Yasuoka Y, Kobayashi M, Sato Y, Nonoguchi H, Tanoue A, Okamoto H, Kawahara K.
Decreased expression of aquqporin 2 in the collecting duct of mice lacking the vasopressin V1a receptor
Clin Exp Nephrol
17/ 2, 183-190
2013/04

10.1007/s10157-012-0686-3
39 Iyoda A, Jiang SX, Travis WD, Kurouzu N, Ogawa F, Amano H, Sato Y, Rusch VW, Saegusa M, Satoh Y.
Clinicopathological features and the impact of the new TNM classification of malignant tumours in patients with pulmonary large cell neuroendocrine carcinoma.
Molecular and Clinical Oncology
1, 437-443
2013/03

10.3892/mco.2013.80
40 Tsumura H, Matsumoto K, Sato Y, Ikeda M, Fujita T, Satoh T, Iwamura M.
Abnormal expression of multiple proteins predicts cancer-specific mortality in patients with high-grade non-muscle-invasive bladder cancer treated with transurethral resection.
Molecular and Clinical Oncology
1, 473-479
2013/03

10.3892/mco.2013.92
41 Yamamoto T, Nakayama K, Hirano H, Tomonaga T, Ishihama Y, Yamada T, Kondo T, Kodera Y, Sato Y, Araki N, Mamitsuka H, Goshima N.
Integrated view of the human chromosome X-centric proteome project.
J Proteome Res
12/ 1, 58-61
2013/01

10.1021/pr300844p
42 Igawa S, Ryuge S, Wada M, Otani S, Maki S, Takakura A, Katono K, Sasaki J, Sato Y, Masuda N.
Pemetrexed for previously treated patients with non-small cell lung cancer and differences in efficacy according to thymidylate synthase expression.
Chemotherapy
58/ 4, 313-320
2012/11
0009-3157
10.1159/000343048
43 Masunaga A, Nagashio R, Iwamoto S, Takeyama N, Sato Y, Miyazaki A, Mitsuya T.
A case of pulmonary adenoma: Possible relationship between tumor histogenesis/tumorigenesis and fibroblast growth factor receptor 2 IIIb.
Pathol Int
62/ 9, 640-645
2012/09

10.1111/j.1440-1827.2012.02841.x
44 Ryuge S, Sato Y, Jiang Shi-X, Wang G, Matsumoto T, Katone K, Inoue H, Iyoda A, Satoh Y, Yoshimura H, Masuda N.
Prognostic impact of nestin in resected large cell neuroendocrine carcinoma of the lung.
Lung Cancer
77/ 2, 415-420
2012/08

10.1016/j.lungcan.2012.03.025
45 Mii S, Niiyama S, Takasu H, Kosaka S, Hara K, Kitasato H, Sato Y, Katsuoka K
Detection of human papillomavirus type 16 in Bowen's carcinoma of the toe.
Int J Dermatol
51/ 7, 804-808
2012/07

10.1111/j.1365-4632.2011.05143.x
46 Suzuki Y, Yoshida T, Wang G, Togano T, Miyamoto S, Miyazaki K, Iwabuchi K, Nakayama M, Horie R, Niitsu N, Sato Y, Nakamura N
Association of CD20 levels with clinicopathological parameters and its prognostic significance for patients with DLBCL
Ann Hematol
91/ 7, 997-1005
2012/07

10.1007/s00277-012-1407-4
47 浅見力也、服部 学、西村由香里、藤田奈央、柿沼廣邦、豊永真澄、横山 大、山下和也、大部 誠、佐藤雄一
液状検体における標本作製法の相違による細胞塗抹量および核面積の比較
日本臨床細胞学会神奈川県支部会誌
17/ 1, 22-28
2012/07


48 Nakayama M, Sato Y, Iwabuchi K, Mikami T, Okamoto M, Seino Y, Okamoto T, Miyamoto S
Laminin-5 immunohistochemical mapping for analysis of local extension in hypopharyngeal cancer: A preliminary report.
Auris Nasus Larynx
39, 301-304
2012/06

10.1016/j.anl.2011.04.017
49 Matsumoto T, Ryuge S, Kobayashi M, Kageyama T, Hattori M, Goshima N, Jiang SX, Saegusa M, Iyoda A, Satoh Y, Masuda N, Sato Y
Anti HuC and HuD autoantibodies are differential sero-diagnostic markers for small cell carcinoma from large cell neuroendocrine carcinoma of the lung.
Int J Oncol
40/ 6, 1957-1962
2012/06

10.3892/ijo.2012.1405
50 Kageyama T, Nagashio R, Ryuge S, Matsumoto T, Iyoda A, Satoh Y, Masuda N, Jiang SX, Saegusa M, Sato Y
HADHA is a potential predictor of the response to platinum-based chemotherapy.
Asian Pacific J Cancer Prev
12/ 12, 3457-3463
2012/04

10.7314/APJCP.2011.12.12.3457
51 Kobayashi M Matsumoto T, Ryuge S, Yanagita K, Nagashio R, Kawakami Y, Goshima N, Jiang SX, Saegusa M, Iyoda A, Satoh Y, Masuda N, Sato Y.
CAXII is a sero-diagnostic marker for lung cancer.
PLoS ONE
7/ 3, e33952
2012/03


52 Amoh Y, Hamada Y, Niiyama S, Eshima K, KawaharaK, Sato Y, Tani Y, Hoffman RM, Katsuoka K
Nestin-positive hair follicle pluripotent stem (hfPS) cells can promote regeneration of regeneration of impinged peripheral-nerve injury.
J Dermatol
39/ 1
2012/01

10.1111/j.1346-8138.2011.01413.x
53 Nagashio R, Sato Y, Matsumoto T, Kageyama T, Hattori M, Iyoda A, Satoh Y, Ryuge S, Masuda N, Jiang SX, Saegusa M
The balance between the expression of hASH1 and HES1 differs between large cell neuroendocrine carcinoma and small cell carcinoma of the lung.
Lung Cancer
74/ 3, 405-410
2011/12

10.1016/j.lungcan.2011.04.012
54 Iyoda A, Travis W, Sarkaria I, Jiang SX, Amano H, Sato Y, Saegusa M, Rusch VW, Satoh Y
Expression of profiling and identification of potential molecular targets for therapy in pulmonary large-cell neuroendocrine carcinoma.
Exp Ther Med
2/ 6, 1041-1045
2011/11

10.3892/etm.2011.343
55 浅見力也、服部 学、西村由香里、柿沼廣邦、豊永真澄、町田大輔、横山 大、山下和也、大部 誠、佐藤雄一
各種細胞保存液を用いた場合における細胞の経時的変化-形態・免疫組織化学・分子病理学的検討-
日本臨床細胞学会神奈川県支部会誌
16/ 1, 21-32
2011/07


56 Mii S, Amoh Y, Kitasato H, Sato Y, Katsuoka K
Nestin expression in Bowen's disease and Bowen's carcinoma associated with human papilloma virus.
Eur J Dermatol
21/ 4, 515-519
2011/07

10.1684/ejd.2011.1391
57 Kobayashi M, Yasuoka Y, Sato Y, Zhou M, Abe H, Kawahaara K, Okamoto H
Upregulation of calbindin D28k in the late distal tubules in the potassium-loaded adrenalectomized mouse kidney.
Clin Exp Nephrol
15, 355-362
2011/06

10.1007/s10157-011-0414-4
58 Masunaga A, Sato Y, Kadofuku T, Iwamoto S, Masuda M, Suzuki S, Suzuki T, Miyazaki T, Mitsuya T
A case of granulocyte colony-stimulating factor and interleukin 6 receptor-producing mediastinal mature cystic teratoma.
Pathol Int
61, 243-247
2011/04

10.1111/j.1440-1827.2010.02641.x
59 Ryuge S, Sato Y, Wang GQ, Matsumoto T, Jiang SX, Katono K, Inoue H, Masuda N
Prognostic significance of nestin expression in resected non-small cell lung cancer.
Chest
134/ 4, 862-869
2011/04
0012-3692
10.1378/chest.10-1121
60 長塩 亮、佐藤雄一
第一部 病理診断に役立つ分子生物学の手技と知識 5. In situ hybridization法 病理診断に役立つ分子生物学
病理と臨床
29/ 臨時増刊号
2011/04
0287-3745

61 Takayama A, Takeda A, Sato Y, Sakai N, Sugimoto T, Uchinuma E
Expression of melanoma antigen gene (MAGE)-A family protein in human cutaneous malignant melanoma.
Kitasato Med J
40, 103-106
2010/09


62 Nagashio R, Sato Y, Matsumoto T, Kageyama T, Satoh Y, Shinichiro R, Masuda N, Goshima N, Jiang SX, Okayasu I.
Expression of RACK1 is a novel biomarker in pulmonary Adenocarcinomas
Lung Cancer
69/ 1, 54-59
2010/07


63 Minami S, Sato Y, Matsumoto T, Kageyama T, Kawashima Y, Kodera Y, Ishii J, Matsumoto K, Nagashio R, Okayasu I
Proteomic Study of Sera from Patients with Bladder Cancer: Usefulness of S100A8 and S100A9 Proteins
Cancer Genomics Proteomics
7/ 4, 181-190
2010/07


64 Tanabe K, Amoh Y, Kanoh M, Takasu H, Sakai N, Sato Y, Katsuoka K.
Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma
Eur J Dermatol
20/ 3, 283-8
2010/05


65 Nagashio R, Sato Y, Matsumoto T, Kageyama T, Satoh Y, Ryuge S, Masuda N, Jiang SX, Okayasu I.
Significant high expression of cytokeratin 7, 8, 18, 19 in pulmonary large cell neuroendocrine carcinomas, compared to small cell lung carcinomas
Pathol Int
60, 71-77
2010/02


66 Miyajima Y, Sato Y, Oka H, Utsuki S, Kondo K, Tanizaki Y, Nagashio R, Tsuchiya B, Okayasu I, Fujii K.
Prognostic Significance of Nuclear DJ-1 Expression in Astrocytoma
Anticancer Res
30/ 1, 265-270
2010/01


67
Human and mouse hair follicles contain both multipotent and monopotent stem cells.
Cell Cycle
8/ 1, 1-2
2009


68
Contribution of the prostaglandin E2/EP2 receptor-signaling pathway in abscess formation in rat zymosan-induced pleurisy
J Pharmacol Exp Ther
331, 860-870
2009/12


69
A new possible lung cancer marker: VGF detection from the conditioned medium of pulmonary large cell neuroendocrine carcinoma-derived cells using secretome analysis.
Int J Biol Markers
24/ 4, 282-285
2009/11


70
Proteomic study of tumor-specific proteins in cerebrospinal fluid of patients with astrocytoma -Usefulness of gelsolin protein-
Pathol Int
59, 797-803
2009/11


71
Intercalated duct cells in the rat parotid gland may behave as tissue stem cells.
Anat Sci Int
84, 148-154
2009/09


72
Human hair follicle pluripotent stem (hfPS) cells promote regeneration of peripheral-nerve injury: An advantageous alternative to ES and iPS cells.
J Cell Biochem
107, 1016-1020
2009/09


73
High expression of HSP47 in ulcerative colitis-associated carcinomas: proteomic approach.
Br J Cancer
101/ 3, 492-497
2009/08


74
Expression of the hair stem cell specific marker ‘nestin’ in epidermal and follicular tumors.
Eur J Dermatol
18/ 5, 518-523
2008


75
MAGE-A protein and MAGE-A10 gene expression in liver metastasis in patients with stomach cancer.
Br J Cancer
99, 350-356
2008


76
Detection of tumor-specific autoantibodies in sera of patients with lung cancer.
LUNG CANCER
62/ 3, 364-373
2008/05


77
Occlusal disharmony attenuates glucocorticoid negative feedback in aged SAMP8 mice.
Neuroscience Letters
427, 71-76
2007


78
Different expressions of growth factor mRNAs in keloids and hypertrophic scars.
Kitasato Med J
37/ 1, 37-42
2007


79
Interaction between cyclooxygenase (COX)-1- and COX-2-products modulates COX-2 expression in the late phase of acute inflammation.
Eur J Pharmacol
559, 210-218
2007


80 Yoshikawa M, Takayasu N, Hashimoto A, Sato Y, Tsukamoto H
The serine racemase mRNA locates in neurons of rat brain.
Arch Histol Cytol vol.70 No.2
127-134
2007/09


81 長塩 亮、佐藤雄一、中島 孝
3部-2-a 基本技術について、直説法、間接法、増感法、抗原賦活方法 診断に役立つ免疫組織化学
病理と臨床
25/ 臨時増刊号, 253-259
2007/03


82
Angiogenic factors in norma endometrium and endometrial adenocarcinoma
Pathol Int
57, 140-147
2007/03


83
Expression of autocrine mortility factor mRNA is a poor prognostic factor in high-grade astrocytoma
PATHOLOGY INTERNATIONAL
56/ 9, 510-515
2006


84
8.病理検査機器 4)自動染色装置 (2)免疫染色 最新臨床検査機器のすべて
Medical Technology
臨時増刊号 34/ 13, 1576-1587
2006


85
ホルマリン固定パラフィン法米標本でどこまでmRNA in situ hybridizationは可能か?ーその有効性と問題点ー
臨床検査
50/ 7, 737-744
2006


86
Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas
J Pathol
210, 431-440
2006


87
Expression of mRNA and protein of serine racemase in primary cultures of rat neurons
Eur J Pharmacol
548, 74-76
2006


88
Differential expression of N-cadherin in normal human tissues
Arch Histol Cytol
69/ 2, 135-145
2006


89
A rapid and highly sensitive in situ mRNA hybridization method with Digoxigenin labeled cRNA probes
J Histotechnol
29, 91-95
2006/06


90
Expression of autocrine motility factor mRNA is a poor prognostic actor in malignant astrocytoma
Pathol Int
56, 510-515
2006/05


91 Tsuchiya B, Sato Y, Kameya T, Okayasu I, Mukai K
Differential expression of N-cadherin and E-cadherin in normal human tissues
Arch Histol Cytol vol.69 No.2
135-145
2006/02


92 Sato Y, Tsuchiya B, Jiang S-X, Okayasu I
Rapid and highly sensitive in situ hybridization method with digoxigenin labeled cRNA probes.
J Histotechnol vol.29 No.2
91-95
2005/06


93 Utsuki S, Oka H, Sato Y, Kawano N, Tsuchiya B, Kobayshi I
Invasive meningioma is associated with a low expression of E-cadherin and beta-catenin.
Clin Neuropathol vol.24
8-12
2005/01


94 Igarashi T, Jiang S-X, Kameya T, Asamura H, Sato Y, Nagai K,
Divergent cyclin B1 expression and Rb/p16/Cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors.
Mod Pathol vol.17 No.12
1259-1267
2004/12


95 Nozawa T, Enomoto T, Koshida Y, Sato Y, Kuranami M
Specific enhanced expression of platelet-derived endothelial cell growth factor in submucosa of human colorectal cancer.
Dis Colon Rectum vol.47 No.12
2093-2100
2004/12


96 Nakayama M, Sato Y, Okamoto M, Hirohashi S
Increased expression of laminin-5 and its prognostic significance in hypopharyngeal cancer
Laryngoscope vol.114
1259-1263
2004/10


97 Utsuki S, Oka H, Sato Y, Tsutiya B, Kondo K, Tanizaki Y, Tanaka S
E, N-cadherin and beta-catenin expression in medulloblastoma and atypical teratoid/rhabdoid tumor.
Neurol Med Chir (Tokyo) vol.44
402-407
2004/08


98 Jiang S-X, Kameya T, Asamura H, Umezawa A, Sato Y, Shinada J I
hASH1 expression is closely correlated with endocrne phenotype and differentiation extent in pulmonary neuroendocrine tumors.
Mod Pathol vol.17 No.3
222-229
2004/03


99 柳澤裕依子、能勢富佐子、市川つわ、佐藤雄一、岩渕啓一、岡安勲
高感度間接法を用いた免疫染色法の有用性-LSAB法との感度の比較
病理と臨床 vol.21 No.12
1433-1437
2003/12


100 Suzuki T, Kadoya Y, Sato Y, Handa K, Kakita A, Yamashina S
Expression of pancreatic endocrine markers in centroacinar cells of normal and regenerating rat pancreas: their possible transformation to endocrine cells.
Arch Histol Cytol vol.66 No.4
347-358
2003/04




プロフィールへ戻る